Cocrystal Pharma Inc
COCP
|
|
| |
|
| Trading Volume | 442 |
|
|
3.00 - 1.38 |
| Market Cap Full | $ 17.1M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 16.8% | -17.1% | 2.6% | -15.4% |
| Q2 | - | 68.9% | 20.7% | -25.5% |
| Q3 | - | -12% | -21.8% | 748.8% |
| Q4 | - | 4.6% | -9.6% | -44.5% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 16.8 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -6.5 | -10.1 | -1.4 | 7.8 | 50 | 9.7 | -23.6 | -12 | - | - | - | - |
| 2023 | |||||||||||
| 45.6 | -31 | 2.1 | 24.2 | -12.2 | 10.7 | 11.3 | 12.8 | -37.7 | -11.2 | 14.5 | -10.5 |
| 2022 | |||||||||||
| -13.1 | -4.4 | 1.9 | -14.6 | -14.9 | 2.5 | -2.4 | 1.3 | 759.3 | -28.7 | 10.5 | -29.6 |
| 2021 | |||||||||||
| 26.5 | -8.7 | -10.5 | -16 | -4.2 | 10.6 | -7.2 | 0.9 | -10.3 | -12.4 | -2.4 | -27.6 |
| 2020 | |||||||||||
| 23.6 | 128.9 | -46.6 | 32.8 | 2.3 | 57.5 | 11.2 | -37.9 | -11.4 | -10.8 | 160.2 | -37 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.6 | -0.5 | -0 | -0.1 |
| Q2 | -0.4 | -3 | -0 | -0.1 |
| Q3 | -0.4 | -0.7 | -0 | -0.1 |
| Q4 | 0 | -0.6 | 1.3 | 0 |
| A | -1.46 | -4.77 | 1.2 | -0.2 |